Every 424B that AKZO NOBEL NV (AKZOF) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow AKZOF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AKZOF filings page.
Akzo Nobel N.V. and Axalta Coating Systems Ltd. provide a supplement to their joint proxy statement/prospectus for the planned share-for-share merger, updating disclosures ahead of Axalta’s August 5, 2026 virtual special meeting. The supplement reflects a Second Amendment to the Merger Agreement and related joinder agreements that add Bermuda merger subsidiaries and refine post‑completion governance of the combined company, including detailed rules for the MergeCo board’s composition, director terms and voting thresholds, with many super‑majority requirements reduced from 75% to two thirds of non‑executive directors.
Axalta also discloses shareholder lawsuits and demand letters alleging disclosure deficiencies; it states it believes these claims are without merit but is voluntarily providing additional detail to avoid expense and delay. The supplement describes Axalta’s engagement of Incentrum for a fee of $12.5 million and expands the summaries of Evercore’s and J.P. Morgan’s valuation work, including discounted cash flow methodologies, key assumptions and implied per‑share equity value ranges for both Axalta and AkzoNobel.
AkzoNobel and Axalta are progressing an all‑stock merger under which Axalta shareholders receive 0.6539 AkzoNobel shares per Axalta share, leaving AkzoNobel holders with about 55% of the combined company and Axalta holders with about 45%. AkzoNobel plans a special cash dividend of €2.5 billion, reduced by any 2026 regular dividends, conditional on completion. Closing is targeted for late 2026 to early 2027, subject to shareholder approvals, regulatory clearances, NYSE listing, payment of the special dividend, works council consultation and other conditions; a €150 million termination fee may apply.
For Q2 2026, revenue was €2,589 million, down 1% year-on-year, while operating income rose 17% to €251 million and adjusted EBITDA edged up to €398 million. For the first half, revenue declined 5% to €4,975 million, operating income increased to €428 million, and adjusted EBITDA was €743 million. Net income attributable to shareholders was €232 million with earnings per share of €1.35.
Net debt at June 30 2026 was €3,127 million and the leverage ratio (net debt/adjusted EBITDA) was 2.2. A provision of €300 million remains for the Project Ichthys litigation, while insurance coverage is up to €500 million. After period-end, Russian entities representing less than 2% of revenue were placed under temporary external administration and will be deconsolidated, with €214 million of net assets and a €49 million cumulative translation loss to be reclassified through income.
Axalta Coating Systems Ltd. is asking shareholders to approve an all-share merger with AkzoNobel N.V. at a special general meeting to be held virtually on August 5, 2026. Under the merger agreement, each issued Axalta common share will convert into 0.6539 AkzoNobel ordinary shares and AkzoNobel will pay a pre-completion distribution equal to €2.5 billion less certain 2026 dividends prior to closing.
Based on quoted market data, the implied value of the merger consideration was approximately $30.25 per Axalta share on November 17, 2025 and approximately $34.36 per share on June 23, 2026. The Axalta Board unanimously recommends shareholders vote FOR the bye-laws amendment, the merger agreement, the advisory compensation proposal and a potential adjournment proposal. The record date for voting is June 11, 2026 and 214,018,930 Axalta common shares were issued as of that date.